Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent
Open Access
- 15 July 2015
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 309 (2) , R189-R195
Abstract
Testosterone (TES) and other androgens exert a direct vasorelaxing action on the vasculature in vitro that is structurally specific and independent of cytosolic androgen receptor (AR). The effects of intravenous androgen infusions on mean arterial blood pressure (BP) and heart rate (HR) were determined in conscious, unrestrained, chronically catheterized, ganglionically blocked (hexamethonium, HEX; 30 mg/kg ip) male Sprague-Dawley (SD) and testicular-feminized male (Tfm; AR-deficient) rats, 16–20 wk of age. BP and HR were recorded at baseline and with increasing doses of androgens (0.375–6.00 μmol·kg−1·min−1iv; 10 min/dose). Data are expressed as means ± SE ( n = 5–8 rats/group). In SD rats, baseline BP and HR averaged 103 ± 4 mmHg and 353 ± 12 beats/min (bpm). TES produced a dose-dependent reduction in BP to a low of 87 ± 4 mmHg (Δ16%), while HR was unchanged (354 ± 14 bpm). Neither BP (109 ± 3 mmHg) nor HR (395 ± 13 bpm) were altered by vehicle (10% EtOH in 0.9% saline; 0.15 ml·kg−1·min−1, iv). In Tfm, TES produced a similar reduction in BP (99 ± 3 to 86 ± 3 mmHg, Δ13%); HR was unchanged (369 ± 18 bpm). In SD, 5β-dihydrotestosterone (genomically inactive metabolite) produced a greater reduction in BP than TES (102 ± 2 to 79 ± 2 mmHg, Δ23%); HR was unchanged (361 ± 9). A 20-μg iv bolus of sodium nitroprusside in both SD and Tfm rats reduced BP 30–40 mmHg, while HR was unchanged, confirming blockade by HEX. Pretreatment of SD rats with neuronal nitric oxide synthase (nNOS) inhibitor (S-methyl-thiocitrulline, SMTC; 20 μg·kg−1·min−1× 30 min) abolished the hypotensive effects of TES infusion on BP (104 ± 2 vs. 101 ± 2 mmHg) and HR (326 ± 11 vs. 324 ± 8 bpm). These data suggest the systemic hypotensive effect of TES and other androgens involves a direct vasodilatory action on the peripheral vasculature which, like the effect observed in isolated arteries, is structurally specific and AR-independent, and involves activation of nNOS.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (HL-080402)
This publication has 52 references indexed in Scilit:
- Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolitesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile DysfunctionJournal of Andrology, 2009
- ErratumThe FASEB Journal, 2008
- Serum Testosterone Levels and Arterial Blood Pressure in the ElderlyHypertension Research, 2005
- Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aortaGeneral Pharmacology: The Vascular System, 1996
- The association of hypotestosteronemia with coronary artery disease in men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertensionJournal Of Hypertension, 1993
- Cardiovascular risks: New insights from FraminghamAmerican Heart Journal, 1988
- The Testicular Feminized Rat: A Naturally Occurring Model of Androgen Independent Brain MasculinizationScience, 1980